. generates liver lesions which occupy 40% of the hepatic volume three weeks after PH. In this work the mechanism This general hypothesis that promotion involves selective for the anti promoting effects of phenobarbital and 3-mitoinhibition of normal hepatocytes and consequent selection methylcholantrene were investigated as well as their effects of resistant cells has been questioned. Other authors suggest on the development of malignant hepatocellular carcinoma that promotion involves selective stimulation of the growth of in the resistant hepatocyte model. Treatment with phenoinitiated cells (10,11). In protocols using weak promoters, the barbital or, especially, 3-methylcholanthrene rendered normitoinhibitory effect of the promoter is not clear (7,9). Even mal rat hepatocytes resistant to the mitoinhibitory effect in the case of 2-AAF applied in less toxic regimens than that of 2-AAF. In combination with 2-AAF/PH, 3-methylcholsuggested by Solt and Farber, it has been claimed that anthrene shortened the regenerative growth period to less this promoter directly stimulates the growth of the initiated than one week. In the Solt -Farber protocol for experi-
that in this model initiated cells demonstrate a marked growth advantage over the surrounding cells which are unable to Compounds exerting a mitoinhibitory effect on normal respond to mitogenic growth stimulation brought about by hepatocytes are potent promoters in the resistant hepatocyte partial hepatectomy or chemical hepatotoxicity (4) . Over the model of chemical carcinogenesis in combination with years this principle has been used to develop a number of stimulation of regenerative growth by partial hepatectomy initiation/promotion protocols involving more than a hundred or treatment with carbon tetrachloride. 2-Acetylaminoinitiators and a multitude of promoters (2, 5, 6 ). With few fluorene (2-AAF) almost completely inhibits liver cell regenexceptions, these protocols generate liver nodules with the eration after partial hepatectomy, allowing only resistant same resistant phenotype as that observed with the resistant cells to participate in regenerative growth. After initiation hepatocyte model. Careful investigations have shown that by diethylnitrosamine and promotion with 2-AAF and many promoters exert a mitoinhibitory effect on normal partial hepatectomy (PH), focal growth of initiated cells hepatocytes, both in vivo and in vitro (1, 4, (7) (8) (9) . generates liver lesions which occupy 40% of the hepatic volume three weeks after PH. In this work the mechanism This general hypothesis that promotion involves selective for the anti promoting effects of phenobarbital and 3-mitoinhibition of normal hepatocytes and consequent selection methylcholantrene were investigated as well as their effects of resistant cells has been questioned. Other authors suggest on the development of malignant hepatocellular carcinoma that promotion involves selective stimulation of the growth of in the resistant hepatocyte model. Treatment with phenoinitiated cells (10, 11) . In protocols using weak promoters, the barbital or, especially, 3-methylcholanthrene rendered normitoinhibitory effect of the promoter is not clear (7, 9) . Even mal rat hepatocytes resistant to the mitoinhibitory effect in the case of 2-AAF applied in less toxic regimens than that of 2-AAF. In combination with 2-AAF/PH, 3-methylcholsuggested by Solt and Farber, it has been claimed that anthrene shortened the regenerative growth period to less this promoter directly stimulates the growth of the initiated than one week. In the Solt -Farber protocol for expericells (12) . mental hepatocarcinogenesis, treatment with phenobarbital
In the case of the resistant hepatocyte model, as well as of or 3-methylcholanthrene during promotion with 2-AAF/ other models for chemical carcinogenesis involving 2-AAF, PH permitted hepatocytes surrounding the focal lesions to the mechanism of the resistance demonstrated by initiated respond with regenerative growth. The foci and surcells has been investigated. The alterations in the phenotype rounding liver grew until the liver/body mass index reached associated with resistance are very complex and involve the control value. With phenobarbital treatment the total constitutive multigenetic changes affecting several cellular focal volume was 20% of the liver volume three weeks processes (13-16). It has been found that during the process after PH, whereas the corresponding value in the case of of selection in connection with promotion, the resistant hepato-3-methylcholanthrene was only 1%. Labelling index data cyte has fewer promoter molecules covalently bound to protein, supported the conclusion that growth of the liver lesions RNA and DNA, suggesting that the toxicity of the compound in the resistant hepatocyte model was dependent on differis reduced (16,17). ential inhibition of normal hepatocyte growth by the proStudies of the expression of drug-metabolizing enzymes and moter and that the size of the foci obtained was related to drug metabolism have shown that preneoplastic liver nodules the length of time after PH required to complete liver express many isoforms of cytochrome P-450 at reduced levels, regeneration. 3-methylcholanthrene induced 2-AAF resistwith the possible exception of the form induced by phenobarance prevented the development of large persistent nodules bital (1, 14, 16, 19, 20) . The rates of hydroxylation of 2-AAF are and hepatocellular carcinoma while phenobarbital delayed all reduced to a considerable extent, varying between 4 and cancer development with several month. The data thus 60% of the control values (21). The rate of formation of Nsupports the idea that the degree of clonal expansion during hydroxy-2-acetylaminofluorene, which is considered to be vital promotion determines the size of the population at risk for for the bioactivation of this compound, decreased to the largest malignant transformation, as well as the final frequency of extent. Furthermore, several drug-conjugating enzymes in the carcinomas.
liver nodules are constitutively induced several-fold, including UDP-glucuronosyltransferase I, several isoforms of glutathione transferase, especially the isoform called 7-7, corresponding Introduction to the π-form in humans, aldehyde dehydrogenases, DTdiaphorase, etc. (16, 22) . Interestingly, the activity of the In experimental hepatocarcinogenesis it has been suggested bioactivating enzyme N-hydroxy-2-AAF sulfotransferase is that the selection process during promotion is the result of differential mitoinhibition (1, 2) , such that only cells resistant markedly reduced in liver nodules (23, 24 ).
In addition, the level of the free radical scavenger glutathione is increased five-fold in liver nodules (19,26), as are glutathione reductase and peroxidase. Ubiquinone, a potent regeneratable intracellular antioxidant, is also increased in amount (26), contributing to the resistance of the cell to various chemical compounds, as well as to radiation. Indeed, two cellular components involved in the cellular resistance i.e., glutathione transferase 7-7 and γ-glutamyltransferase, a membranous amino acid pump responsible for supplying the γ-glutamic acid necessary for glutathione synthesis, are used as markers for preneoplastic liver nodules.
In the present study we have performed a series of experiments designed to clarify the mechanism by which potent enzyme inducers affect promotion by 2-AAF. 2-AAF is a rendered resistant to mitoinhibition by 2-AAF and thereby eliminated the basis for differential mitoinhibition. Such induction prevented promotion. When promotion was thus prevented, with phenobarbital alone, phenobarbital and partial hepatectomy, 3-methylcholanthrene alone or 3-methylcholanthrene tumor development was inhibited or reduced significantly. These data confirm that differential mitoinhibition is the and partial hepatectomy. It is well known that 3-methylcholantrene and phenobarbital mechanism underlying promotion by 2-AAF in the resistant hepatocyte model of chemical carcinogenesis.
are mitogenes by themselves, but this effect only lasts for a few days. Treatment with these substances has at the time of partial hepatectomy been going on for seven days, why no Materials and methods further proliferative effect by these compounds were expected.
110 g Male Wistar rats were delivered from Møllegaards Breeding Center,
As shown in the upper part of Table I , the mitogenic effect Ejby, Denmark, and acclimatized to our animal room for one week before was almost totally gone. In rats of this age the basal liver use. The animal room was maintained at standard temperature and humidity with a twelve hour light-dark cycle.
growth corresponded to a 7% weight gain in one week. The showed no effect at all in this respect. After partial hepatectomy,
The antibodies for immunohistochemistry were supplied by Dakopatts AB liver weight gain in the control group during the week following (Box 13, 125 21 Ä lvsjö, Sweden.). Standard procedures were used for histochemical and immunohistochemical surgery corresponded to an increase of 199% of the remaining staining. Double staining of bromodeoxyuridine or proliferating cell nuclear one-third of the liver i.e. the original liver weight had been antigen and glutathione transferase 7-7 was performed in two consecutive restored. From this table it can be seen that treatment with steps, starting with staining of the marker for proliferation with PAP and phenobarbital and 3-methylcholantrene resulted in a reduced continuing with the nodule marker using alkaline phosphatase to visualize the rate of regeneration in both cases and that weight gain were immunocomplex. Enzyme assays were performed as described elsewhere (27). The number of cells necessary for labelling indices calculation was determined decreased to 109% and 146%, respectively.
by calculation of the accumulated mean value. Routinely, 600-800 cells were
In order to confirm the effects of these 'classic' inducers counted after random selection under high magnification. In the case of liver on drug metabolizing enzymes, the total content of cytochrome nodule all the cells in at least six different nodules in each lobe were counted.
P-450 was determined by differential spectroscopy of micro- case of rats killed 21 days after partial hepatectomy, these pellets were inserted
The ability of 2-AAF to inhibit regeneration after partial 72 hours before killing. When indicated, rats were not treated with 2-AAF.
hepatectomy, as well as the ability of phenobarbital and 3-All rats were killed by decapitation and therefore allowed to bleed, in order methylcholanthrene respectively to prevent mitoinhibition by to reduce blood pooling in the liver. The livers were weighed and slices from 2-AAF were studied using animals initiated with diethylnitrosaeach lobe were fixed in neutral buffered 4% formaldehyde.
mine, 200 mg/kg BW. Figure 2 illustrates the results obtained. Liver regeneration subsequent to partial hepatectomy without Results 2-AAF treatment corresponded to a 103% weight increase after three days, compared to the remaining one-third of the Table I documents basal data on weight gain and hepatic labelling indices for untreated rats, as well as for rats treated liver, and 130% after seven days in initiated rats. It was Table I . Body weight increase and hepatocyte BrdU-labelling indices in untreated rats and in non-initiated rats treated with phenobarbital, 3-methylcholanthrene and partial hepatectomy (PH) as indicated in Figure 1 . Rats were not fed 2-acetylaminofluorene. The data presented are from the timepoints corresponding to the week following partial hepatectomy in the resistant hepatocyte model and are the means of Ϯ sd of five rats. Measurements are done in all liver lobes. Statistic analysis is done in comparison with respective control group. Significant difference according to student t-test is written * ϭ P Ͻ 0.05; ** ϭ P Ͻ 0.01; *** ϭ P Ͻ 0.001.
Treatment
Labelling index Liver weight increase at 7 days (%) showed no significant difference between the groups, which means that in this case drug treatment did not effect regenerative growth rate in the nodules. In surrounding tissue 3-methylcholanthrene induced drug resistance in the livers, thus permitting the hepatocytes to respond to regenerative growth stimulus as well and to restore liver weight in a short period of time, i.e., less than one week. Phenobarbital had a limited effect on the labelling index in surrounding cells, but the liver weight gain and nodular volume fraction did demonstrate that phenobarbital also acted in the same manner as 3-methylcholanthrene, albeit less potently. After 21 days labelling index in the complete promotion group was still rather high in both surrounding and nodular tissue due to remaining regenerative growth. When treated with 3-methylcholantrene labelling index was significantly lower, not only in surrounding tissue, but also in nodules. Figures 3 and 4 present histological slides from the livers of rats subjected to the complete promotion protocol, with and without 3-methylcholanthrene treatment. The sections taken nodules occupied almost 40% of the liver volume 21 days after partial hepatectomy. In 3-methylcholanthrene-treated rats, obvious that 2-AAF was acting as a mitoinhibitor, reducing both the nodules and surrounding cells grew initially. After the ability for regeneration after partial surgical liver removal. one week, growth rate was reduced and at 21 days after partial Upon treatment with this xenobiotic, the remaining liver tissue hepatectomy these focal lesions were still tiny, having enjoyed only increased its weight 36% after three days and 59% after a growth advantage for only a short period of time. seven days. Complete recovery of liver weight was not
The effects of these treatments during promotion on maligobserved until several weeks after termination of exposure to nant transformation and survival are presented in Table III . 2-AAF and, in this case, could to a large extent be accounted for
With complete promotion, all rats died from hepatocellular by nodular growth. With simultaneous phenobarbital treatment carcinomas within less than one year. The phenobarbitalduring 2-AAF feeding, the rate of regeneration was partially treated rats also developed malignant liver tumors, but survived restored, i.e., weight increases of 74% in three days and 125% for a longer period of time. 3-Methylcholanthrene-treated rats in seven days were seen. 3-Methylcholanthrene completely that did not die of non-tumor-related diseases before the age prevented mitoinhibition by 2-AAF, permitting growth of the of one year survived for a long time. One of these rats lived remaining liver tissue by 103% after three days and 206% until the completion of our experiment after 99 weeks. At this after seven days. Thus, the original liver weight was completely time, only one rat had developed liver cancer. The same rat restored one week after partial hepatectomy in this case.
had a malignant mesenchymal tumor just below its diaphragm, Table II shows the liver regeneration data and the growth but most of the animals were free of tumors. In the control of liver nodules in the complete resistant hepatocyte model group not exposed to 2-AAF during promotion the rats survived depicted in Figure 1 . We measured labelling index both in for a long time. One of these rats killed at the end of the surrounding tissue and in the nodules to elucidate where experiment had a small aberrant carcinoma of the liver. the treatment had its effect and the degree of differential mitoinhibition. After seven days, labelling index in the nodules Histologically, this tumor was poorly differentiated, but was Liver section from the resistant hepatocyte model using promotion 7 days after partial hepatectomy. The section was stained twice complete promotion ϩ 3-methylcholanthrene 7 days after partial using antibodies against glutathione S-transferase (cytoplasmic) and hepatectomy. The section was stained twice using antibodies against bromodeoxyuridine (nuclear). A liver nodule is seen at the top, surrounding glutathione S-transferase (cytoplasmic) and bromodeoxyuridine (nuclear). A tissue at the bottom. X 400. (B) Liver section from the resistant hepatocyte liver nodule is seen at the center. X 250. (B) Liver section from the model with complete promotion 21 days after partial hepatectomy. The resistant hepatocyte model using complete promotion ϩ 3-section was stained immunohistochemically using antibodies against methylcholanthrene 21 days after partial hepatectomy. The section was glutathione S-transferase. X 25.
stained immunohistochemically using antibodies against glutathione Stransferase. X 25.
probably of hepatocellular origin with signs of cholangiocellular differentiation. One of the rats in this group had an of 2-AAF is inhibition of cell proliferation, rendering cells adenocarcinoma in its kidney.
incapable of responding to regenerative growth stimulation (4, 30) . In the resistant hepatocyte model, initiated cells resistant Discussion to mitoinhibition by 2-AAF are selected to grow and to respond to growth stimulation achieved by surgical or chemical In 2-AAF-induced carcinogenesis the effect of this compound has been shown to be associated with formation of the reactive hepatectomy (3). It has therefore been suggested that in this model, promotion is mediated by mitoinhibition of the nitrenium ion and subsequent covalent binding of this ion to cellular macromolecules (28,29). One of the cytotoxic effects surrounding, non-initiated hepatocytes, but not of initiated cells, thus permitting them to respond to regenerative growth methylcholantrene and phenobarbital has been shown to counteract the carcinogenic effect of 2-acetylaminofluorene (47, 48) . stimulation. This mechanism is referred to as promotion through differential mitoinhibition (2, 4) .
With the protocols used by many authors mechanisms are indicated and suggested. In this work our aim was to proceed Many promoters have been shown to exhibit their promoting ability under conditions where they inhibit normal hepatocyte further in mechanistic implementation and also relate the manipulation in promotion with the development of cargrowth. Recently, it was shown that ethinylestradiol does not act as a promoter in the initial phase when liver cell proliferation cinomas.
When the rats were treated with 2-AAF in combination with is reduced, but only after weeks of treatment, when the hormone acts as an hepatocyte mitoinhibitor (31). The concept one of these inducers, the inhibition of regeneration by 2-AAF was counteracted by phenobarbital and, furthermore, almost of differential mitoinhibition has been subject to much debate and attack from investigators arguing that promoters act as totally eliminated by 3-methylcholanthrene, resulting in a rapid restoration of liver weight and termination of regenerative selective growth-stimulating agents (10) (11) (12) .
In this investigation we have employed the knowledge that hepatocyte proliferation. Thus, when this strategy was applied to the resistant hepatoliver foci and nodules consist of cells demonstrating major alterations in drug metabolism, rendering them resistant to the cyte model, we can conclude by measuring liver weight increase, labelling index within the nodules and in the surtoxic effects of a multitude of compounds. Many different molecular alterations may help explain the low levels of rounding tissue, that promotion by differential mitoinhibition was eliminated and selection and clonal expansion of initiated reactive metabolites and covalently bound molecules within these resistant cells. The first step in xenobiotic metabolism cells counteracted or inhibited. Using the original protocol, 2-AAF inhibited regeneration for a considerable period, even (phase I) is slower in liver nodules than in normal hepatocytes, primarily due to reduced levels of cytochrome P-450 after termination of exposure to the carcinogen. Substantial proliferation in the surrounding cells was observed two weeks (21,32,33). The result is a marked reduction in the overall rate of 2-AAF metabolism and, especially, in the formation of the after removal of the mitoinhibitor, a sign of continuous stimulation of regenerative liver cell proliferation. Liver N-hydroxylated metabolite. The rates of the following steps, phase II, conjugations and excretion, are increased in nodular nodules grew in response to this stimulus to reach a volume corresponding to almost 40% of the total hepatic volume. tissue, because of elevated activities of the enzymes involved, primarily glucuronosyl transferase, but also glutathione-S transSelective conditions were not at all evident when 3-methylcholanthrene was added to the promotion protocol involving 2-AAF ferases (14,16,21,22,32). Remarkably, N-hydroxy-2-AAF sulfotransferase activity is very low in cells from liver nodules and partial hepatectomy. In this case foci grew for only a few days, until regeneration was completed. Two weeks after the (23), reducing their capacity to form the unstable sulfate ester which precedes the formation of the ultimate reactive termination of treatment the labelling indices in the tissue surrounding the liver foci and in the foci themselves were metabolite, the nitrenium ion. This final reactive species exerts its toxic effects on the cell through the formation of adducts only at background levels. The clonal expansion up to this time-point was limited, resulting in a total focus volume less (17,19,33). Meerman et al., (34-36) have shown that inhibition of N-hydroxy-2-AAF sulfotransferase activity by pentachlorothan 1% of the total liver volume. The frequencies of malignant transformation in the different phenol reduces the binding of metabolites of N-hydroxy-2-AAF to cellular components. groups were proportional to the volume fraction of the liver occupied by lesions after promotion. Using the original protoIf resistance is conferred by these differences in metabolic activities, normal hepatocytes should demonstrate increased col, all the animals died showing signs of malignant hepatocellular tumor within one year after commencement of the resistance to mitoinhibition by 2-AAF if excretion of this compound could be made more efficient. Phenobarbital and experiment. The limited effect of phenobarbital did not alter the frequency of carcinomas, but did prolong mean survival 3-methylcholanthrene are well characterized inducers of drugmetabolizing enzymes with different induction profiles (37) .
time by 18 weeks. 3-Methylcholanthrene treatment delayed or prevented maligAlthough different from each other, the enzyme induction profile of each of these compounds demonstrates similarities nant transformation in most rats, so that tumors did not appear before the animals died of other causes. As an unexpected to that observed after 2-AAF treatment.
It has been shown by several authors that 3-methylcholside-effect, four rats in this group died of infectious diseases. Four of these rats, however, lived longer than any of the anthrene induces the rate of 2-AAF metabolism and excretion (28,37,38), along with a change in the cytochrome P-450 animals subjected to complete promotion. Only one of the 3-methylcholanthrene-treated rats developed a malignant tumor, pattern which increases ring hydroxylation on carbon atoms 3 and 5 of 2-AAF, i.e., directs metabolism towards less toxic succumbing to a large sarcoma in the abdomen 71 weeks after initiation. This rat also exhibited a tumor in the liver that products. In addition, UDP-glucuronyl transferase I is induced dramatically by 3-methylcholanthrene (39-41) thus increasing could be seen to be a hepatoma by microscopic examination. In the control group promoted using partial hepatectomy alone the capacity of hepatocytes for glucuronidation and excretion. Phenobarbital treatment does not change the overall rate of 2-without a selector, one rat developed a liver carcinoma of an aberrant type. This rat lived through the entire experiment, at AAF metabolism, but does decrease the production of Nhydroxy-2-AAF (37). Hayes has shown that pretreatment with which time it was killed. Another rat in this group developed a malignant tumor in its kidney. 3-methylcholantrene-, phenobarbital and PCBЈs with effects like these compounds in the Solt and Farber model inhibits
The results of the work presented here strengthen the hypothesis suggested by others that differential mitoinhibition the mitoinhibitory effect of 2-AAF on hepatocytes surrounding nodules seven days after partial hepatectomy. This treatment is the mechanism of action involved in the resistant hepatocyte model using 2-AAF and partial hepatectomy as the promotion also diminished selective nodule enlargement over a four week examination period (49) . In other model systems 3- regimen. 
